Columbus、OHにおける過体重の臨床試験
Columbusとその周辺地域（約30マイル以内）の拠点で、過体重に関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
被験者募集中第3相
- Centricity Research - Ohio, Columbus
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
被験者募集中第1相
- Ohio Clinical Trials, Columbus
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
被験者募集中第3相
- Remington-Davis, Inc, Columbus
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Columbus
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
被験者募集中第3相
- Nationwide Children's Hospital, Columbus
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
被験者募集中第3相
- Endocrinology Associates Inc, Columbus
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
被験者募集中第3相
- AURORA-1 Clinical Site, Columbus
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
被験者募集中第3相
- AURORA-2 Clinical Site, Columbus
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
被験者募集中第3相
- Remington Davis Inc, Columbus
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
被験者募集中第3相健康なボランティア歓迎
- ACCOMPLISH-2 Research Site, Columbus
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Columbus
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
被験者募集中第3相
- ACCOMPLISH-1 Research Site, Columbus
- ACCOMPLISH-1 Research Site, Columbus
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
被験者募集中観察研究
- The Ohio State University, Columbus
他の都市における過体重の試験
- San Antonio, TX34件の研究
- Houston, TX33件の研究
- Chicago, IL28件の研究
- Orlando, FL27件の研究
- Las Vegas, NV23件の研究
- Miami, FL23件の研究
- Atlanta, GA20件の研究
- Dallas, TX20件の研究
- New York City, NY19件の研究
- Jacksonville, FL19件の研究
- Washington, DC19件の研究
- Austin, TX18件の研究
Columbusにおける他の研究
- 非小細胞肺癌56件の研究
- 乳がん39件の研究
- 卵巣がん39件の研究
- がん（全種類）38件の研究
- 肺がん37件の研究
- 急性骨髄性白血病35件の研究
- 慢性リンパ性白血病28件の研究
- 転移性癌27件の研究
- 子宮内膜がん25件の研究
- 大腸癌24件の研究
- 前立腺がん24件の研究
- 多発性骨髄腫24件の研究
ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。